期刊文献+

中枢神经系统疾病的基因治疗 被引量:2

The gene therapy of central nervous system disorders
下载PDF
导出
摘要 基因治疗正在成为常规方法难以治愈的中枢神经系统疾病的新的治疗手段。本文概要介绍了中枢神经系统疾病基因治疗的方法和途径 ;中枢神经系统疾病基因治疗的病毒载体以及目前中枢神经系统疾病基因治疗研究的状况。 Gene therapy is a potential and new methods of treating many neurological diseases that were considered refractory to current conventional treatments. By injection of viral vectors or transplantation of genetically engineered cells into specific sites of the brain, the development of technologies for delivery of foreign genes into brain opened the field to promising treatments for CNS disorders. But the development of gene therapy for neurological diseases represents a more complex problem than that for other systemic disorders. Incomplete characterization of target organs (brain and spinal cord) and additional challenges, such as post mitotic cells, heterogeneity of cell types and circuits, and limited access, all contribute to the difficulties. For this reason, this report provides an update outline of gene therapy in CNS and reviews current researches in this filed.
出处 《基础医学与临床》 CSCD 北大核心 2002年第3期206-211,218,共7页 Basic and Clinical Medicine
基金 国家重点基础研究规划 (G19990 5 4 0 0 8)
关键词 中枢神经系统疾病 基因治疗 病毒载体 gene therapy central nervous system viral vectors Corresponding author: Wang Xiao min
  • 相关文献

参考文献29

  • 1[1]Costantini LC, Bakowska JC, Breakefield XO, et al. Gene therapy in the CNS[J]. Gene Ther, 2000,7: 93-109.
  • 2[2]Englund U, Ericson C, Rosenblad C, et al. The use of a recombinant lentiviral vector for ex vivo gene transfer into the rat CNS[J]. Neuroreport, 2000,11: 3973-3977.
  • 3[3]Kafri T, van Praag H, Gage FH, et al. Lentiviral vectors: regulated gene expression[J]. Mol Ther, 2000, 1:516-521.
  • 4[4]Peel AL, Klein RL. Adeno-associated virus vectors: activity and applications in the CNS[J]. J Neurosci Methods, 2000,98:95-104.
  • 5[5]Klein RL, Mandel RJ, Muzyczka N. Adeno-associated virus vector-mediated gene transfer to somatic cells in the central nervous system[J]. Adv Virus Res, 2000,55:507-528.
  • 6[6]Natsume A, Mata M, Goss J, et al. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induceddegeneration[J]. Exp Neurol, 2001,169:231-238.
  • 7[7]Berry M, Barrett L, Seymour L, et al.Gene therapy for central nervous system repair[J]. Curr Opin Mol Ther, 2001,3: 338-349.
  • 8[8]Bemelmans AP, Horellou P, Pradier L, et al.Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer[J]. Hum Gene Ther, 1999,10: 2987-2997.
  • 9[9]Ghodsi A. Extensive beta-glucuronidase activity in murine central nervous system after adenovirus-mediated gene tranfer to brain[J]. Hum Gene Ther, 1998,9: 2331-2340.
  • 10[10]Snyder EY, Taylor RM, Wolfe JH. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain[J]. Nature, 1995,374:367-370.

同被引文献23

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部